auranofin , an orally active gold preparation , was compared with sodium aurothiomalate in a double-blind trial in patients with rheumatoid arthritis fulfilling the ara criteria , who had been stabilized on sodium aurothiomalate for at least six months .
C0004320
auranofin
C0018026
gold